Scribe Therapeutics to Collaborate With Biogen to Develop CRISPR-based Genetic Medicines for Neurological Diseases, Including Amyotrophic Lateral Sclerosis Read more
ImmunoGen Announces FDA Breakthrough Therapy Designation for IMGN632 in Relapsed or Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm Read more
FDA Grants GlycoMimetics Rare Pediatric Disease Designation for Rivipansel for Treatment of Sickle Cell Disease Read more
Eureka Therapeutics Announces Initiation of ARYA-1 Clinical Trial to Evaluate ET140203 ARTEMIS T Cell Therapy in Hepatocellular Carcinoma Read more
SpringWorks Therapeutics Announces Clinical Collaboration with Pfizer Inc. to Evaluate Nirogacestat in Combination with PF‐06863135 Read more
Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics Read more
NVIDIA Announces Partnership with GSK’s AI-Powered Lab for Discovery of Medicines and Vaccines Read more